Johnson & Johnson (JNJ) vs Pfizer Inc. (PFE)
A side-by-side comparison of Johnson & Johnson and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
JNJ
Johnson & Johnson
$265.58HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
PFE
Pfizer Inc.
$27.72HealthcareDelayed quote: Sep 11, 2026, 4:01 PM EDT
Total return — JNJ vs PFE
growth of $100 · dividends reinvested · last 10yJNJ +201.9% (+11.7%/yr)PFE +37.3% (+3.2%/yr)JNJ compounded faster over this window
JNJ PFE
JNJ vs PFE: by the numbers
- •JNJ is the larger company ($640.02B vs $157.99B market cap).
- •JNJ trades at the lower trailing earnings multiple (30.77 vs 36.63 P/E), one valuation lens rather than an overall verdict.
- •JNJ converts more revenue to profit (21.48% vs 6.81% net margin).
- •PFE grew revenue faster over the past five years (6.29% vs 2.93% CAGR).
- •PFE pays the higher dividend yield (6.19% vs 1.98%).
Metrics side by side
Valuation
| Metric | JNJ | PFE |
|---|---|---|
| P/E ratio | 30.77 | 36.63 |
| Forward P/E | 22.93 | 9.32 |
| P/S ratio | 6.54 | 2.48 |
| P/B ratio | 7.53 | 1.85 |
| EV / EBITDA | 19.66 | 10.15 |
| FCF yield | 2.92% | 6.95% |
Profitability
| Metric | JNJ | PFE |
|---|---|---|
| Gross margin | 70.45% | 71.32% |
| Operating margin | 26.81% | 25.08% |
| Net margin | 21.48% | 6.81% |
| ROE | 24.76% | 5.09% |
| ROIC | 13.89% | 9.33% |
Dividends
| Metric | JNJ | PFE |
|---|---|---|
| Dividend yield | 1.98% | 6.19% |
| Payout ratio | 61.18% | 227.27% |
Growth (annualized)
| Metric | JNJ | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 2.93% | 6.29% |
| EPS CAGR (5Y) | 14.61% | -3.78% |
| FCF CAGR (5Y) | -2.05% | -3.11% |
| Total return CAGR (5Y) | 12.90% | -4.68% |
Frequently asked
- Which has the lower trailing P/E, JNJ or PFE?
- JNJ has the lower trailing P/E: JNJ trades at 30.77 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, JNJ or PFE?
- Over the past five years, PFE grew revenue faster — JNJ at a 2.93% CAGR versus PFE at 6.29%.
- Does JNJ or PFE pay a bigger dividend?
- JNJ yields 1.98% and PFE yields 6.19% based on trailing dividends and the latest price.
- Is JNJ or PFE more profitable?
- JNJ runs the higher net margin — JNJ at 21.48% versus PFE at 6.81%.
- How have JNJ and PFE total returns compared?
- Over the past 10 years, JNJ delivered 11.45% and PFE delivered 3.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Johnson & Johnson P/E ratioPfizer P/E ratioJohnson & Johnson dividend yieldPfizer dividend yieldJohnson & Johnson ROEPfizer ROEJohnson & Johnson operating marginPfizer operating marginJohnson & Johnson revenue growthPfizer revenue growthJohnson & Johnson free cash flowPfizer free cash flow
Johnson & Johnson & Pfizer appear in these rankings
Highest Dividend Yield Stocks25+ Year Dividend GrowersHighest FCF Yield StocksLargest Companies by Market Cap
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.